Key result
Hydra TAVI leads to delayed fatal type A aortic dissection in an enlarged aorta.
Why the study?
Acute aortic dissection is an exceptionally rare but potentially fatal complication of TAVI that is typically recognized periprocedurally, though delayed presentations after apparently uncomplicated procedures have also been reported.
Case Report (n=1)
No
Delayed Stanford type A aortic dissection is a rare, potentially fatal complication that must be considered in patients presenting with chest pain following TAVI, particularly those with pre-existing ascending aortic dilatation, even when initial ECG and troponin findings are normal.
Answers are grounded in this paper and cite their sources.
Consider delayed type A dissection in post-TAVI chest pain with aortic dilatation; this case leaves open risk-stratification strategies.
Acute aortic dissection is an exceptionally rare but potentially fatal complication of transcatheter aortic valve implantation (TAVI).Although most cases are recognized during or shortly after the procedure, delayed presentations following apparently uncomplicated TAVI have also been reported.An 81-year-old woman with severe symptomatic aortic stenosis and pre-existing ascending aortic dilatation of 45 mm underwent successful transfemoral TAVI with a 26-mm Hydra self-expanding transcatheter heart valve.Seven days later, she presented with sudden severe retrosternal chest pain radiating to the back and neck.Despite hemodynamic stability, a non-ischemic electrocardiogram, and normal serial high-sensitivity cardiac troponin I levels, the clinical presentation raised suspicion of acute aortic syndrome.Transthoracic echocardiography revealed an intimal flap in the ascending aorta.Emergency computed tomography angiography confirmed Stanford type A aortic dissection with associated intramural hematoma.The patient was immediately referred for emergency cardiothoracic surgery but deteriorated and died before definitive repair could be performed.Delayed aortic dissection should be considered in patients presenting with new severe chest pain after TAVI, even following an apparently uncomplicated procedure and in the presence of initially reassuring hemodynamic, electrocardiographic, and biomarker findings.Pre-existing ascending aortic dilatation may represent a vulnerable anatomical substrate and warrants careful consideration during pre-procedural assessment.A low threshold for urgent multimodality imaging is essential to facilitate early diagnosis and management of this rare but life-threatening complication.
No takes yet. Share an insight, caveat, or question.
Kyvetos et al. (2026) conducted a case report in Severe symptomatic aortic stenosis with pre-existing ascending aortic dilatation (45 mm) (n=1). Transfemoral transcatheter aortic valve implantation (TAVI) with a 26-mm Hydra self-expanding transcatheter heart valve was evaluated on Delayed Stanford type A acute aortic dissection and mortality. Transfemoral TAVI with a 26-mm Hydra valve in an 81-year-old woman with a 45-mm ascending aorta was complicated by fatal Stanford type A aortic dissection 7 days post-procedure.
Synapse has enriched 10 related papers. Consider them for comparative context: